Parties d'ouvrages collectifs (1)

  1. 1. Spruyt, D., Gillet, C., & Rasschaert, J. (2018). Bone and bone marrow; interactions. In Encyclopedia of Endocrine Diseases (pp. 31-39). Elsevier. doi:10.1016/B978-0-12-801238-3.66157-3
  2.   Articles dans des revues avec comité de lecture (106)

  3. 1. Sidiras, P., Lechanteur, J., Imbault, V., Sokolova, T., Durez, P., Gangji, V., Communi, D., & Rasschaert, J. (2022). Human carbamylome description identifies carbamylated α2-macroglobulin and hemopexin as two novel autoantigens in early rheumatoid arthritis. Rheumatology (Online), 61(7), 2826-2834. doi:10.1093/rheumatology/keab838
  4. 2. Sidiras, P., Lechanteur, J., Imbault, V., Sokolova, T., Durez, P., Gangji, V., Communi, D., & Rasschaert, J. (2021). Human carbamylome description identifies carbamylated α2-macroglobulin and hemopexin as two novel autoantigens in early rheumatoid arthritis. Rheumatology. doi:10.1093/rheumatology/keab838
  5. 3. La, C., Lê, P. Q., Ferster, A., Spruyt, D., Goffin, L., Lauwerys, B. B., Durez, P., Boulanger, C., Sokolova, T., Rasschaert, J., & Badot, V. (2021). Serum calprotectin (S100A8/A9): A promising biomarker in diagnosis and follow-up in different subgroups of juvenile idiopathic arthritis. RMD Open, 7(2), 001646. doi:10.1136/rmdopen-2021-001646
  6. 4. Hernigou, J., Vertongen, P., Rasschaert, J., & Hernigou, P. (2021). Role of scaffolds, subchondral, intra-articular injections of fresh autologous bone marrow concentrate regenerative cells in treating human knee cartilage lesions: Different approaches and different results. International journal of molecular sciences, 22(8), 3844. doi:10.3390/ijms22083844
  7. 5. Sidiras, P., Spruyt, D., Gangji, V., Imbault, V., Sokolova, T., Durez, P., Communi, D., Rasschaert, J., & Badot, V. (2020). Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases. Scandinavian journal of rheumatology, 1-6. doi:10.1080/03009742.2020.1798500
  8. 6. Sidiras, P., Spruyt, D., Gangji, V., Imbault, V., Sokolova, T., Durez, P., Communi, D., Rasschaert, J., & Badot, V. (2020). Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases. Scandinavian journal of rheumatology. doi:10.1080/03009742.2020.1798500
  9. 7. Dalla Valle, A., Vertongen, P., Spruyt, D., Lechanteur, J., Suain, V., Gaspard, N., Brion, J. P., Gangji, V., & Rasschaert, J. (2019). Induction of Stearoyl-CoA 9-Desaturase 1 Protects Human Mesenchymal Stromal Cells Against Palmitic Acid-Induced Lipotoxicity and Inflammation. Frontiers in endocrinology, 10, 726. doi:10.3389/fendo.2019.00726
  10. 8. Hernigou, J., Vertongen, P., Chahidi, E., Kyriakidis, T., Dehoux, J. P., Crutzen, M., Boutry, S., Larbanoix, L., Houben, S., Gaspard, N., Koulalis, D., & Rasschaert, J. (2018). Effects of press-fit biphasic (collagen and HA/βTCP) scaffold with cell-based therapy on cartilage and subchondral bone repair knee defect in rabbits. International orthopaedics, 42(7), 1755-1767. doi:10.1007/s00264-018-3999-3
  11. 9. Gangji, V., Soyfoo, M. S., Heuschling, A., Afzali, V., Moreno Reyes, M. R., Rasschaert, J., Gillet, C., Fils, J. F., & Hauzeur, J.-P. (2018). Non traumatic osteonecrosis of the femoral head is associated with low bone mass. Bone, 107, 88-92. doi:10.1016/j.bone.2017.11.005
  12. 10. Gillet, C., Dalla Valle, A., Gaspard, N., Spruyt, D., Vertongen, P., Lechanteur, J., Rigutto, S., Dragan, E.-R., Heuschling, A., Gangji, V., & Rasschaert, J. (2017). Osteonecrosis of the Femoral Head: Lipotoxicity Exacerbation in MSC and Modifications of the Bone Marrow Fluid. Endocrinology, 158(3), 490-502. doi:10.1210/en.2016-1687
  13. 11. La, C., Stordeur, P., Smet, J., Franchimont, D., Lauwerys, B. B., Lê, P. Q., Goffin, L., Boulanger, C., Ferster, A., Brasseur, J. P., Brasseur, B., Tuerlinckx, D., Spruyt, D., Rasschaert, J., De Maertelaer, V., Kleimberg, S., Sokolova, T., Durez, P., & Badot, V. (2016). Place du dosage de la calprotectine sérique comme biomarqueur d'intérêt dans l'arthrite juvénile idiopathique. Revue du rhumatisme, 83, A60-A61. doi:10.1016/S1169-8330(16)30246-0

  14. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Suivant >>